The malleability of market boundaries and aggressive AI competition among online services should help rebut claims that not only Google, but Facebook and Amazon as well, are somehow illegal monopolies.
The hipster antitrust narrative about Internet “monopolies” runs headlong into the reality of fierce artificial intelligence competition among the largest tech companies in the emerging voice-controlled digital assistant space.
We should not return to an era when rivals were able to make strategic and unprincipled use of antitrust doctrine to demand special treatment to save themselves from the brutal consequences of competitive failure. America should not let antitrust itself become anticompetitive.
A five-decade consensus on the objectives of antitrust law is under threat today from the extraordinarily divisive politics of contemporary America. It took a long time and sordid episodes to get the politics out of antitrust—it would be a shame to go backwards and politicize competition policy again.
Former music and film producer Jonathan Taplin is way out of his element, merging two distinct issues into a superficial “#resistance” meme that contradicts the central tenets of U.S. antitrust law.
By harnessing the business incentives of generic drug firms to limit the anticompetitive power of branded pharmaceutical patent holders, the CREATES Act represents a straight-forward solution to a market failure created by exploitation of legal loopholes in drug industry regulation. It is a remedy that should be strongly supported by the White House and enacted by the new Congress.
The year 2016 was momentous in politics and celebrity deaths, but also in the field of technology law. Here’s our wrap-up of the five most significant tech cases that hit the judiciary in the past year.
My first Constant Contact email was a holiday wish to our clients. And here is is. Merry Christmas.
It’s been a few years since the district court’s judgment in the landmark Microsoft monopolization case. Brian, Bill and I were all just a tad younger in 2000, don’t you think?
American drug prices are among the highest in the world, the result of a long pattern of anticompetitive tactics in the highly concentrated pharmaceuticals market.